You are here:

Home
NICE Guidance
Conditions and diseases
Neurological conditions
Headaches

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine

Technology appraisal guidance
Reference number: TA260
Published: 27 June 2012

Guidance
Tools and resources
Information for the public
Evidence
History

Migraine (chronic) - botulinum toxin type A: consultee and commentator comments on the ACD

Migraine (chronic) - botulinum toxin type A: Allergan
Migraine (chronic) - botulinum toxin type A: Migraine Action
Migraine (chronic) - botulinum toxin type A: Migraine Trust
Migraine (chronic) - botulinum toxin type A: Association of British Neurologists
Migraine (chronic) - botulinum toxin type A: British Association for the Study of Headache (BASH)
Migraine (chronic) - botulinum toxin type A: British Pain Society
Migraine (chronic) - botulinum toxin type A: Migraine in Primary Care Advisors
Migraine (chronic) - botulinum toxin type A: Primary Care Neurology Service
Migraine (chronic) - botulinum toxin type A: Royal College of Nursing
Migraine (chronic) - botulinum toxin type A: Royal College of Physicians
Migraine (chronic) - botulinum toxin type A: Department of Health
Migraine (chronic) - botulinum toxin type A: Medicines and Healthcare Products Regulatory Agency (MHRA)

This page was last updated: 02 January 2015